Sun Life/$SLF
1D1W1M3M6MYTD1Y5YMAX
Capital at risk
About Sun Life
Sun Life Financial is one of the Big Three Canadian life insurers. The Canadian business contributed around 35% of its 2025 adjusted earnings. In that segment, the firm provides health, life insurance, and annuity products to individual and group customers. Its US business is mostly group health and contributed about 17% of the firm's adjusted earnings in 2025. Sun Life also offers life insurance and wealth products in several Asian markets with a strong presence in Hong Kong and the Philippines. The Asia segment contributed around 18% of adjusted 2025 earnings. Its asset management business had around CAD 1.2 trillion in total assets under management or administration at the end of 2025 and represents around 30% of the firm's earnings.
- Ticker
- $SLF
- Sector
- Finance
- Primary listing
- NYSE
- Employees
- 32,151
- Headquarters
- Toronto, Canada
- Website
- www.sunlife.com
Sun Life Metrics
BasicAdvanced
$45B
19.08
$4.23
0.83
$2.71
3.44%
Price and volume
Market cap
$45B
Beta
0.83
52-week high
$84.38
52-week low
$57.22
Average daily volume
396K
Dividend rate
$2.71
Financial strength
Current ratio
53.577
Quick ratio
50.161
Long term debt to equity
0.579
Total debt to equity
0.58
Dividend payout ratio (TTM)
63.11%
Interest coverage (TTM)
9.01%
Profitability
EBITDA (TTM)
3,928.977
Gross margin (TTM)
40.88%
Net profit margin (TTM)
9.52%
Operating margin (TTM)
14.15%
Effective tax rate (TTM)
22.08%
Revenue per employee (TTM)
$794,090
Management effectiveness
Return on assets (TTM)
0.78%
Return on equity (TTM)
13.09%
Valuation
Price to earnings (TTM)
19.079
Price to revenue (TTM)
1.764
Price to book
2.57
Price to tangible book (TTM)
6.62
Price to free cash flow (TTM)
13.8
Free cash flow yield (TTM)
7.25%
Free cash flow per share (TTM)
5.843
Dividend yield (TTM)
3.36%
Forward dividend yield
3.44%
Growth
Revenue change (TTM)
4.08%
Earnings per share change (TTM)
4.87%
3-year revenue growth (CAGR)
6.16%
10-year revenue growth (CAGR)
2.20%
3-year earnings per share growth (CAGR)
8.16%
10-year earnings per share growth (CAGR)
5.96%
3-year dividend per share growth (CAGR)
8.51%
10-year dividend per share growth (CAGR)
8.93%
What the Analysts think about Sun Life
Analyst ratings (Buy, Hold, Sell) for Sun Life stock.
Analyst projections of the future price of Sun Life stock.
Bulls say / Bears say
Underlying net income rose 11% and earnings per share rose 13% in Q2 2026, with growth across Canada, Asia and the US. Return on equity reached 19.1%. (Sun Life)
Hong Kong new business annualised premium equivalent grew 44% in the first half of 2026, against market growth of 10%. Growth across broker, agency and bancassurance channels points to strong demand and distribution reach. (Sun Life Hong Kong)
MFS faced worsening outflows: net withdrawals reached US$22.9 billion in Q2, up from US$14.3 billion a year earlier. Continued investor preference for other US equity strategies could weigh on asset-management earnings. (Sun Life)
The US dental business still faces significant Medicaid volume declines, which management said would suppress earnings this year. The shift towards a more profitable mix may take one to two years. (The Motley Fool)
Reported earnings remain sensitive to markets: Q1 2026 net income fell 50% year on year amid unfavourable market impacts, then Q2 net income rose 41%, helped by favourable equity and other market effects. That swing makes headline results less predictable than underlying earnings. (Sun Life, Sun Life)
Data summarised monthly by Lightyear AI. Last updated on 31 Oct 2026.
Sun Life Financial Performance
Revenues and expenses
Sun Life Earnings Performance
Company profitability
Upcoming events
No upcoming events
Sun Life News
AllArticlesVideos
Funds containing Sun Life
AllUSDEURGBP
Fund name | Fund size | $SLF weighting |
|---|---|---|
iShares MSCI Canada€SXR2 | $2.4B | 1.46% |
iShares MSCI Canada£CSCA | $2.4B | 1.46% |
SPDR S&P Global Dividend Aristocrats£GBDV | $1.8B | 0.90% |
SPDR S&P Global Dividend Aristocrats$GLDV | $1.8B | 0.90% |
iShares Ageing Population$AGED | $953M | 0.53% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.